CD47 and neoplasm: The CD47 enabled cancer cells to escape innate and adaptive immune surveillance leading to metastatic spread, which could be restricted by the administration of anti-CD47 antibodies through affecting tumor growth and tumor microenvironment signaling (16, 17).